Browsing "Pharmacology" by Keyword : Disease Models, Animal
Showing results 17 to 28 of 28
| Pub Year | | Title | Author(s) |
| 2011 | | Microglial P2X₇ receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease. | 곽병주, 이용범 |
| 2017 | | Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease | 박상면 |
| 2016 | | P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma | 박상면, 박해심, 신유섭 |
| 2019 | | Parkinson's disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes | 김현미, 박상면, 이지훈, 조은혜, 주일로 |
| 2006 | | Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. | 곽병주 |
| 2019 | | Protective Effects of Serotonin and its Derivatives, N-Feruloylserotonin and N-(p-Coumaroyl) Serotonin, Against Cisplatin-Induced Renal Damage in Mice | 양시영 |
| 2014 | | Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury. | 박상면, 우현구, 주일로 |
| 2020 | | Seomae mugwort and jaceosidin attenuate osteoarthritic cartilage damage by blocking IkappaB degradation in mice | 강이중, 양시영 |
| 2021 | | Small heterodimer partner (SHP) aggravates ER stress in Parkinson’s disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation | 이지훈, 조은혜, 주일로 |
| 2010 | | The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury. | 곽병주, 노재성, 조성익 |
| 2003 | | The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors. | 곽병주 |
| 2021 | | Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model | 양시영 |
1
